GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

103 hedge funds and large institutions have $87.5M invested in Sanofi Contingent Value Rights in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

Holders
103
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.04M
2
+$253K
3
+$78K
4
HCM
Highbridge Capital Management
New York
+$17.7K
5
Goldman Sachs
Goldman Sachs
New York
+$9.75K

Top Sellers

1
-$335K
2
-$161K
3
-$70K
4
TL
TowerView LLC
New York
-$58.6K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$57.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$4K
52
$3.06K
53
$2K
54
$2K
55
$1K
56
$1K
57
$1K
58
$1K
59
$1K
60
$1K
61
$1K
62
$1K
63
$442
64
$132
65
$73
66
$56
67
$42
68
$8
69
–
70
–
71
–
72
–
73
–
74
–
1 2
3